Related Experiment Video
Updated: Sep 24, 2025

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Pulmonary hypertensive crisis in children with pulmonary arterial hypertension undergoing cardiac catheterization
Qiangqiang Li1, Chen Zhang1, Rong Wang2
1Department of Pediatric Cardiology, Beijing Anzhen Hospital Capital Medical University Beijing China.
Insights
Pulmonary hypertensive crisis (PHC) during right heart catheterization (RHC) is a significant risk for pediatric pulmonary arterial hypertension (PAH) patients. Sedation and severe right ventricle dilation independently predict PHC in these children.
Area of Science:
- Pediatric Cardiology
- Critical Care Medicine
- Pulmonary Hypertension Research
Background:
- Pediatric pulmonary arterial hypertension (PAH) patients face risks of pulmonary hypertensive crisis (PHC) or death during right heart catheterization (RHC).
- Identifying risk factors is crucial for improving procedural safety in this vulnerable population.
Purpose of the Study:
- To identify the risks and clinical characteristics associated with PHC in pediatric PAH patients undergoing diagnostic RHC.
- To analyze predictors of PHC in this cohort.
Main Methods:
- Retrospective analysis of 163 RHC procedures in 147 pediatric PAH patients (January 2007-December 2020).
- Data collected included patient demographics, NYHA class, anesthetic methods, and echocardiographic indices.
- Multivariate logistic regression was used to identify independent predictors of PHC.
Main Results:
- PHC occurred in 11.7% of procedures; 3.1% required cardiac compression, and 0.6% died.
- Patients experiencing PHC were more likely to be in NYHA class III-IV, require sedation, and have higher peak tricuspid regurgitation velocity and RV/LV ratio.
- Independent predictors for PHC were the need for sedation and a higher RV/LV ratio.
Conclusions:
- RHC carries significant risks for children with PAH, especially those with severe right ventricle dilation requiring sedation.
- Comprehensive pre-procedural evaluation, close monitoring, and tailored treatment are essential to mitigate PHC risks and reduce mortality.
Abstract:
Pediatric patients with pulmonary arterial hypertension (PAH) are considered to be at risk for pulmonary hypertensive crisis (PHC) or even death during right heart catheterization (RHC). This retrospective study was designed to identify the risks and clinical characteristics associated with PHC in pediatric PAH patients. We included 163 consecutive procedures from 147 pediatric patients diagnosed with PAH who underwent diagnostic RHC in Beijing Anzhen Hospital between January 2007 and December 2020. The average patient age was 9.0 ± 4.7 years and 84 (51.5%) were females. Before RHC, over 20% of patients were in New York Heart Association (NYHA) class III-IV. Sedation or general intravenous anesthesia was used in 103 procedures (63.2%), with spontaneous breathing in 93.2%. PHC occurred in 19 patients (11.7%), 5 (3.1%) required cardiac compression, and 1 died (0.6%). Compared to patients without PHC, those who experienced PHC were more likely to be in NYHA class III-IV (p = 0.012) before RHC, require sedation (p = 0.011), had echocardiographic indices of higher peak tricuspid regurgitation velocity (p = 0.018), and right ventricle (RV) to left ventricle (LV) ratio (p < 0.001). Multivariate logistic regression for PHC identified the need for sedation and a higher RV/LV ratio as independent predictors. In conclusion, the risk of RHC remains significant in children with PAH, particularly in those with severe RV dilation who require sedation during cardiac catheterization. Comprehensive evaluation, close monitoring, and appropriate treatment before and during the procedure are essential for reducing mortality.
More Related Videos
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
08:51Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model
Published on: November 11, 2022
Related Concept Videos
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization I: Pre-Procedure Overview
Pulmonary Embolism I: Introduction
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Cardiac Catheterization IV: Nursing Management